The cellular origin of the neoplastic elements in the different histopathological forms of Hodgkin's disease, and of the pathognomonic Steinberg-Reed cell in particular, are unknown1 2 and have been a subject of considerable debate. At various times, and based on criteria of differing validity, the Steinberg-Reed cell has been proposed to have a T lymphoid,3 B lymphoid,47 or myeloid origin. 8 In a large series of patients with Hodgkin's disease who were followed up about 5% developed a second malignancy,9 which represents a striking increase in incidence compared with that in the normal population. Although many malignancies were of a haemopoietic origin, there was no consistent pattern which might have suggested the origin to be Hodgkin's disease. The termination of Hodgkin's disease in a true leukaemic phase is a rare event10-12 and clearly provides an opportunity for detailed analysis of the nature and origin of the malignant cell concerned.
We report a case of nodular sclerosing Hodgkin's disease terminating in a leukaemia, which was typified by the presence of multinucleate blast cells with many of the morphological features of Stemnberg-Reed cells. Immunophenotypic analysis showed the cells to be of myeloid origin.
Case report
A 62 year old man presented in November 1981 with clinical stage IVB Hodgkin's disease of nodular sclerosing histological type. The appearances of a peripheral blood sample and bone marrow aspirate were normal. He was treated with six cycles of chemotherapy comprising mustine, vinblastine, proAccepted for publication 6 January 1987 carbazine, and prednisolone, and clinical remission was achieved. In November 1983 he had an infradiaphragmatic relapse; this was confirmed by examination of a lymph node biopsy specimen, which showed lymphocyte depleted Hodgkin's disease. At this time the appearances of a peripheral blood sample, bone marrow aspirate, and trephine biopsy specimen were normal. Four cycles of etoposide, vincristine, and adriamycin were given, but, although he responded well, computed tomography scans showed persistent lymphadenopathy. Chromosomal analysis was performed using standard methods.
Results
Histological examination of the lymph node biopsy specimen obtained for diagnosis and subsequent assessment and tissue obtained at necropsy showed typical nodular sclerosing Hodgkin's disease transforming to lymphocyte depleted type. Necropsy tissue samples were not available for phenotypic exam- ination.
Examination of peripheral blood samples and bone marrow aspirates in the leukaemic phase showed large blast cells with basophilic cytoplasm, some of which had prominent nucleoli and cytoplasmic granulation. Most blast cells were finely positive with Sudan black and non-specific esterase staining. In addition, there was a substantial population of large binucleated and multinucleated blast cells (fig 1) .
The table summarises the results of phenotypic analysis of the mononuclear cells obtained from The only lymph node available for frozen section immunophenotyping dated from the last biopsy. Sections were examined for the presence of cells marked by Ki-l and CD1 5 (TG1) monoclonal antibodies, which are known to idenify Sternberg-Reed cells.15 16 No positive cells were found, but the material available was largerly sclerotic and hypocellular with few Hodgkin's cells.
Chromosomal analysis of the patient's blast cells showed a great diversity of karyotype with features typical of karyotype instability. The cells ranged from hypodiploid to hyperdiploid (41-96 chromosomes) with numerous, but inconsistent, translocations, fragments, and marker chromosomes. The most common rearrangements were: t(l0; 18) (pl1; pl1), 50% of cells; t(l 1; 17) (p15; p1 1), 20% of cells.
Discussion
Previous studies on the cellular origin of Hodgkin's disease have failed to reach a consensus. Moreover, it is still debatable whether the Sternberg-Reed cell, the presence of which is a prerequisite for the diagnosis, is even neoplastic. Immunological studies df Stemnberg- Reed Firstly, the leukaemia developed at an early stage when Hodgkin's disease was evident at a number of nodal sites but was not responding to treatment. This temporal association suggests, but does not prove, that the two disease processes were related. Secondly, the morphological similarity between the binucleate leukaemic blast cells and Stemnberg-Reed cells certainly supports this view, as does the neoplastic nature of the blast cells as judged by karyotype; however, as the immunological phenotype of the two cells could not be compared there can be no formal proof in this case. Thirdly, there was no prodromal phase of bone marrow hypoplasia or evidence of dyshaemopoiesis preceding the development of leukaemia. Finally, the karyotypic abnormalities were not typical of a secondary leukaemia.
The immunophenotyping of the blast cells from peripheral blood and bone marrow, both mononucleate and multinucleate, in this case provides strong evidence for a myeloid origin. There was no expression of B or T lymphoid markers, which contrasts with the clear lymphoid origin of the case reported by Linch et al. 2 There is increasing evidence to support the view that Hodgkin's disease forms a complex of clinicopathological conditions, and it would therefore not be surprising that the nature of the rare cases of leukaemic transformation of Hodgkin's disease was also heterogeneous. Until the neoplastic cell(s) of Hodgkin's disease can be identified and isolated from the mixed cell population of the nodal lesions these rare leukaemias will provide the only means of analysing the origin of this intriguing disease. We acknowledge the support of the Imperial Cancer Research Fund.
